Literature DB >> 1651808

The infrequent association of systemic lupus erythematosus and solid tumors.

A Sulkes1, Y Naparstek.   

Abstract

The authors describe the clinical course of two patients with long-standing, indolent systemic lupus erythematous (SLE) who developed, respectively, a breast carcinoma and a malignant melanoma 8 and 15 years after the diagnosis of lupus; both patients died with evidence of widespread, rapidly progressive metastatic disease at a time when the SLE was minimally active and did not require immunosuppressive therapy. The association of SLE and solid tumors in the same patient is reviewed. The frequency of this association appears to be low and the most often described tumors are of uterine and bladder origin. The clinical course of the solid malignancy in these patients is not always described in detail. Careful epidemiologic studies on the true incidence of solid tumors in patients with SLE are required to better understand this association.

Entities:  

Mesh:

Year:  1991        PMID: 1651808     DOI: 10.1002/1097-0142(19910915)68:6<1389::aid-cncr2820680635>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  [Vesicle, light hypersensitivity, mouth ulceration and arthralgia in a 40-year-old patient. Bullous systemic lupus erythematosus].

Authors:  A Kolb-Mäurer; S Herzog; C Sitaru; C Kneitz; D Zillikens; M Goebeler
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

2.  p185, an immunodominant epitope, is an autoantigen mimotope.

Authors:  Sanjeev Kumar; John A Hinks; Joseph Maman; Chelliah T Ravirajan; Laurence H Pearl; David A Isenberg
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

3.  Systemic lupus erythematosus associated with primary large cell carcinoma of the lung.

Authors:  H Irie; H Satoh; T Akama; Y T Yamashita; H Ishikawa; M Ohtsuka
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

4.  IgG deposits can be detected in cell nuclei of patients with both lupus erythematosus and malignancy.

Authors:  Ingrid Böhm
Journal:  Clin Rheumatol       Date:  2007-03-16       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.